Stem cells: promising options for alternative medical therapeutic approaches

CellGenix has announced the launch of the CellGenix PSC Kit, containing Basal Medium and Supplement. The serum-free and defined culture system is optimised for efficient feeder-free expansion of human pluripotent stem cells (hPSC), like human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC).

Human pluripotent stem cell research is an expanding field that has potential to change the way human diseases are studied and treated. Because of their ability to differentiate into all adult cell types, they are already useful tools for drug development and modeling of diseases and open up new avenues for regenerative medicine.

CellGenix PSC Kit is highly suitable for the efficient and stable cultivation of pluripotent stem cells. Human PSCs cultured in the two-component kit system show a significant expansion rate and the typical morphology of undifferentiated hESC and hiPSC lines, coupled with a stable karyotype and full pluripotent differentiation potential.

CellGenix has more than 20 years in-house expertise in GMP manufacturing and development of cell therapy and regenerative medicine products. It offers a comprehensive product portfolio, such as preclinical and GMP grade cytokines and serum-free media for cell therapy applications.

Recent Issues